There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Global Blood Therapeutics (GBT – Research Report) and Rocket Pharmaceuticals (RCKT – Research Report) with bullish sentiments. Global Blood Therapeutics (GBT) In a report issued on May 5, Raju Prasad from William Blair maintained a Buy rating on Global Blood Therapeutics. The company's shares closed last Friday at $26.87, close to its 52-week low of $24.61. According to TipRanks.com, Prasad has 0 stars on 0-5 stars ranking scale with an average return of -20.9% and a 19.2% success rate.
https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-global-blood-therapeutics-gbt-rocket-pharmaceuticals-rckt?utm_source=advfn.com&utm_medium=referral
Rocket Pharmaceuticals (NASDAQ:RCKT)
Historical Stock Chart
From Jul 2022 to Aug 2022 Click Here for more Rocket Pharmaceuticals Charts.
Rocket Pharmaceuticals (NASDAQ:RCKT)
Historical Stock Chart
From Aug 2021 to Aug 2022 Click Here for more Rocket Pharmaceuticals Charts.